Even though it was proved the impact of HO-1 modulation in cancer cell proliferation, obviously the enzymatic inhibition cannot be considered as the only practicable treatment strategy for cancer therapy, but it represents a therapeutic option, as adjuvant, in order to increase tumor cells sensibility to chemo and radiotherapy [202]. This evidence concerns the gene HMOX1 and cancer.